Aim: The purpose of this study is to determine the prevalence of urinary incontinence in the 12-month postpartum period and the risk factors related to this condition. Methods: The research is a cross-sectional study of 1,749 first-year postpartum women living in the metropolis of Konya and presenting at seven city health centers. The statistical methods used were the χ2, the Student’s t test and logistic regression analysis. Results: Of the women in the study who were in their 12-month postpartum periods, 19.5% were experiencing varying degrees of urinary incontinence. While 42.2% of the women suffered from stress incontinence, 10.3% had urge incontinence, 47.5% complained of a mixed type of urinary incontinence, 7.3% reported leakage of urine during sexual intercourse and 14.4% reported the need to use protective pads. It was found that 12.3% of the women were performing pelvic floor muscle exercises and only 15.2% had consulted their doctors about urinary incontinence. Conclusion: It was seen that urinary incontinence is a serious health problem in the postpartum period, that it disrupts a woman’s daily activities, affects her sex life but that despite this, women do not receive needed medical assistance.

Keywords:
Postpartum, Urinary incontinence, Prevalence, Risk factors, Adverse health effects
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.